Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers

被引:330
作者
Giustarini, Daniela [1 ]
Dalle-Donne, Isabella [2 ]
Tsikas, Dimitrios [3 ]
Rossi, Ranieri [1 ]
机构
[1] Univ Siena, Dept Evolutionary Biol, Lab Pharmacol & Toxicol, I-53100 Siena, Italy
[2] Univ Milan, Dept Biol, Milan, Italy
[3] Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany
关键词
Anti-oxidants; bioanalytical validation; biomarker(s) of oxidative stress; clinical trials; free radicals; human diseases; nitrosative stress; oxidative damage; oxidative stress; reactive nitrogen species; reactive oxygen species; TOTAL ANTIOXIDANT CAPACITY; VITAMIN-E SUPPLEMENTATION; CHROMATOGRAPHY-MASS-SPECTROMETRY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HORMONE REPLACEMENT THERAPY; PLASMA-LIPID PEROXIDATION; LONG-TERM SUPPLEMENTATION; BLOOD MONONUCLEAR-CELLS; C-REACTIVE PROTEIN; DAMAGE IN-VIVO;
D O I
10.3109/10408360903142326
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Oxidative stress has been related increasingly to the onset and/or progression of a growing number of human diseases. However, large studies on supplementation with anti-oxidants for prevention or treatment of different pathologies have yielded contradictory and mostly negative results, as documented by numerous meta-analyses and clinical trials. Here we analyze in detail the findings of these studies and discuss major aspects that, in our opinion, are likely to be responsible for these confounding data. With the belief that a clear correlation between disease and oxidative stress is far from being proven for most pathological conditions, our argument focuses on the following points: i) choice of biomarker(s) and/or the biological system(s) for the analyses; ii) pitfalls in pre-analytical and analytical methods for assessing oxidative stress; and iii) scientific misconduct. Eventually, suggestions aiming to obtain more convergent results on this topic are provided.
引用
收藏
页码:241 / 281
页数:41
相关论文
共 295 条